GlassScriptPhysician profile
Silvio Marra
NPI 1235198383
$3,117.28
in general payments reported to CMS, 2019-2025
26 companies · $948 in 2025
The $948 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $286 · 2021: $314 · 2022: $471 · 2023: $542 · 2024: $417 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $727.51 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $278.04 | 2019-2025 | Dupixent |
| Alk-Abello, INC | $273.73 | 2019-2025 | Grastek, Ragwitek, Odactra |
| Glaxosmithkline, LLC. | $243.64 | 2021-2025 | Nucala |
| Smith+Nephew, INC. | $223.23 | 2020-2025 | Tula, Halo |
| Integra Lifesciences Corporation | $196.18 | 2022-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Stryker Corporation | $151.47 | 2020-2025 | Xpress Loprofile, Clarifix |
| Phathom Pharmaceuticals, INC. | $146.01 | 2025 | Voquezna |
| Olympus America INC. | $141.84 | 2025 | Rhino-Laryngo Videoscope |
| Intersect Ent, INC. | $84.42 | 2020-2021 | |
| Medtronic, INC. | $82.45 | 2021-2023 | Pteye Parathyroid Detection System |
| Merck Sharp & Dohme LLC | $76.35 | 2020-2023 | |
| Acclarent, INC | $67.88 | 2021 | |
| Inspire Medical Systems, INC. | $65.86 | 2023-2025 | Inspire |
| Optinose US, INC. | $65.76 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xoran Technologies LLC | $56.12 | 2020 | |
| Abbvie INC. | $53.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $35.20 | 2019 | |
| Ambu INC. | $29.05 | 2020 | |
| Aerin Medical INC. | $20.42 | 2022 | |
| Hologic Sales and Service, LLC | $19.80 | 2023 | Coolseal Generator |
| Checkpoint Surgical, INC | $19.59 | 2021 | |
| Covidien LP | $18.67 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.70 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $14.30 | 2023 | Ryaltris |
| Itamar Medical INC | $8.71 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silvio Marra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.